Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Schistosomal extracellular vesicle-enclosed miRNAs modulate host T helper cell differentiation.

Meningher T, Barsheshet Y, Ofir-Birin Y, Gold D, Brant B, Dekel E, Sidi Y, Schwartz E, Regev-Rudzki N, Avni O, Avni D.

EMBO Rep. 2020 Jan 7;21(1):e47882. doi: 10.15252/embr.201947882. Epub 2019 Dec 11.

PMID:
31825165
2.

Design of a basigin-mimicking inhibitor targeting the malaria invasion protein RH5.

Warszawski S, Dekel E, Campeotto I, Marshall JM, Wright KE, Lyth O, Knop O, Regev-Rudzki N, Higgins MK, Draper SJ, Baum J, Fleishman SJ.

Proteins. 2020 Jan;88(1):187-195. doi: 10.1002/prot.25786. Epub 2019 Aug 2.

3.

Probing cellular mechanics with acoustic force spectroscopy.

Sorkin R, Bergamaschi G, Kamsma D, Brand G, Dekel E, Ofir-Birin Y, Rudik A, Gironella M, Ritort F, Regev-Rudzki N, Roos WH, Wuite GJL.

Mol Biol Cell. 2018 Aug 8;29(16):2005-2011. doi: 10.1091/mbc.E18-03-0154. Epub 2018 Jun 21.

4.

Non-diffracting beams for label-free imaging through turbid media.

Nagar H, Dekel E, Kasimov D, Roichman Y.

Opt Lett. 2018 Jan 15;43(2):190-193. doi: 10.1364/OL.43.000190.

PMID:
29328235
5.

Prediction of multidimensional drug dose responses based on measurements of drug pairs.

Zimmer A, Katzir I, Dekel E, Mayo AE, Alon U.

Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10442-7. doi: 10.1073/pnas.1606301113. Epub 2016 Aug 25.

6.

Identification and classification of the malaria parasite blood developmental stages, using imaging flow cytometry.

Dekel E, Rivkin A, Heidenreich M, Nadav Y, Ofir-Birin Y, Porat Z, Regev-Rudzki N.

Methods. 2017 Jan 1;112:157-166. doi: 10.1016/j.ymeth.2016.06.021. Epub 2016 Jun 25.

PMID:
27350362
7.

Glucose becomes one of the worst carbon sources for E.coli on poor nitrogen sources due to suboptimal levels of cAMP.

Bren A, Park JO, Towbin BD, Dekel E, Rabinowitz JD, Alon U.

Sci Rep. 2016 Apr 25;6:24834. doi: 10.1038/srep24834.

8.

Dynamics inside the cancer cell attractor reveal cell heterogeneity, limits of stability, and escape.

Li Q, Wennborg A, Aurell E, Dekel E, Zou JZ, Xu Y, Huang S, Ernberg I.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2672-7. doi: 10.1073/pnas.1519210113. Epub 2016 Feb 29.

9.

Hierarchy of non-glucose sugars in Escherichia coli.

Aidelberg G, Towbin BD, Rothschild D, Dekel E, Bren A, Alon U.

BMC Syst Biol. 2014 Dec 24;8:133. doi: 10.1186/s12918-014-0133-z.

10.

Linear superposition and prediction of bacterial promoter activity dynamics in complex conditions.

Rothschild D, Dekel E, Hausser J, Bren A, Aidelberg G, Szekely P, Alon U.

PLoS Comput Biol. 2014 May 8;10(5):e1003602. doi: 10.1371/journal.pcbi.1003602. eCollection 2014 May.

11.

Promoter activity dynamics in the lag phase of Escherichia coli.

Madar D, Dekel E, Bren A, Zimmer A, Porat Z, Alon U.

BMC Syst Biol. 2013 Dec 30;7:136. doi: 10.1186/1752-0509-7-136.

12.

Promoters maintain their relative activity levels under different growth conditions.

Keren L, Zackay O, Lotan-Pompan M, Barenholz U, Dekel E, Sasson V, Aidelberg G, Bren A, Zeevi D, Weinberger A, Alon U, Milo R, Segal E.

Mol Syst Biol. 2013 Oct 29;9:701. doi: 10.1038/msb.2013.59.

13.

Response to comment on "Evolutionary trade-offs, Pareto optimality, and the geometry of phenotype space".

Shoval O, Sheftel H, Shinar G, Hart Y, Ramote O, Mayo A, Dekel E, Kavanagh K, Alon U.

Science. 2013 Feb 15;339(6121):757. doi: 10.1126/science.1228921.

PMID:
23413339
14.

Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta.

Madar S, Harel E, Goldstein I, Stein Y, Kogan-Sakin I, Kamer I, Solomon H, Dekel E, Tal P, Goldfinger N, Friedlander G, Rotter V.

PLoS One. 2013 Apr 22;8(4):e61353. doi: 10.1371/journal.pone.0061353. Print 2013.

15.

The last generation of bacterial growth in limiting nutrient.

Bren A, Hart Y, Dekel E, Koster D, Alon U.

BMC Syst Biol. 2013 Mar 25;7:27. doi: 10.1186/1752-0509-7-27.

16.

p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition.

Brosh R, Assia-Alroy Y, Molchadsky A, Bornstein C, Dekel E, Madar S, Shetzer Y, Rivlin N, Goldfinger N, Sarig R, Rotter V.

Cell Death Differ. 2013 Feb;20(2):312-20. doi: 10.1038/cdd.2012.125. Epub 2012 Sep 21.

17.

Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species.

Kalo E, Kogan-Sakin I, Solomon H, Bar-Nathan E, Shay M, Shetzer Y, Dekel E, Goldfinger N, Buganim Y, Stambolsky P, Goldstein I, Madar S, Rotter V.

J Cell Sci. 2012 Nov 15;125(Pt 22):5578-86. doi: 10.1242/jcs.106815. Epub 2012 Aug 16.

18.

Mode of regulation and the insulation of bacterial gene expression.

Sasson V, Shachrai I, Bren A, Dekel E, Alon U.

Mol Cell. 2012 May 25;46(4):399-407. doi: 10.1016/j.molcel.2012.04.032.

19.

Evolutionary trade-offs, Pareto optimality, and the geometry of phenotype space.

Shoval O, Sheftel H, Shinar G, Hart Y, Ramote O, Mayo A, Dekel E, Kavanagh K, Alon U.

Science. 2012 Jun 1;336(6085):1157-60. doi: 10.1126/science.1217405. Epub 2012 Apr 26.

20.

Using bleach-chase to measure protein half-lives in living cells.

Geva-Zatorsky N, Issaeva I, Mayo A, Cohen A, Dekel E, Danon T, Cohen L, Liron Y, Alon U, Eden E.

Nat Protoc. 2012 Mar 29;7(4):801-11. doi: 10.1038/nprot.2012.028.

PMID:
22461069

Supplemental Content

Support Center